BNGO Stock Forecast: BioNano Genomics jumps by nearly 10% on Saphyr adoption in U.K. labsNEWS |
4/22/2021 2:09:00 PM GMT
|
By Stocks Reporter
NASDAQ:BNGO added 9.85% on Wednesday as the broader markets enjoyed a rare day in the green.
BioNano’s Saphyr system has been adopted by two major labs in the U.K. which are owned by NHS.
BNGO is ramping up its development as it plans to release the prototype for its next generation of Saphyr later this year.
Update April 24: BioNano Genomics Inc (NASDAQ: BNGO) shares have kicked off Thursday's session with an increase of nearly 10% to around $6.50. As detailed below, the gene-related company is venturing into the British market and that provides fresh prospects for higher incomes. The gains recorded on Thursday complete a third consecutive day of gains after BNGO shares lost ground throughout most of April.